507 related articles for article (PubMed ID: 28555885)
21. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Jesudian AB; Jacobson IM
Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
[TBL] [Abstract][Full Text] [Related]
22. Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis.
Trilianos P; Selaru F; Li Z; Gurakar A
Digestion; 2014; 89(2):165-73. PubMed ID: 24577150
[TBL] [Abstract][Full Text] [Related]
23. Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.
Vesterhus M; Holm A; Hov JR; Nygård S; Schrumpf E; Melum E; Thorbjørnsen LW; Paulsen V; Lundin K; Dale I; Gilja OH; Zweers SJLB; Vatn M; Schaap FG; Jansen PLM; Ueland T; Røsjø H; Moum B; Ponsioen CY; Boberg KM; Färkkilä M; Karlsen TH; Lund-Johansen F
J Hepatol; 2017 Jun; 66(6):1214-1222. PubMed ID: 28161472
[TBL] [Abstract][Full Text] [Related]
24. Pathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis.
Grimsrud MM; Folseraas T
Liver Int; 2019 Dec; 39(12):2230-2237. PubMed ID: 31216595
[TBL] [Abstract][Full Text] [Related]
25. Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis.
Li L; Masica D; Ishida M; Tomuleasa C; Umegaki S; Kalloo AN; Georgiades C; Singh VK; Khashab M; Amateau S; Li Z; Okolo P; Lennon AM; Saxena P; Geschwind JF; Schlachter T; Hong K; Pawlik TM; Canto M; Law J; Sharaiha R; Weiss CR; Thuluvath P; Goggins M; Shin EJ; Peng H; Kumbhari V; Hutfless S; Zhou L; Mezey E; Meltzer SJ; Karchin R; Selaru FM
Hepatology; 2014 Sep; 60(3):896-907. PubMed ID: 24497320
[TBL] [Abstract][Full Text] [Related]
26. Identification of fucosylated Fetuin-A as a potential biomarker for cholangiocarcinoma.
Betesh L; Comunale MA; Wang M; Liang H; Hafner J; Karabudak A; Giama NH; Moser CD; Miyoshi E; Roberts LR; Block TM; Mehta A
Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28561948
[TBL] [Abstract][Full Text] [Related]
27. Primary sclerosing cholangitis and cholangiocarcinoma.
Lazaridis KN; Gores GJ
Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
[TBL] [Abstract][Full Text] [Related]
28. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.
Patsenker E; Wilkens L; Banz V; Osterreicher CH; Weimann R; Eisele S; Keogh A; Stroka D; Zimmermann A; Stickel F
J Hepatol; 2010 Mar; 52(3):362-9. PubMed ID: 20137822
[TBL] [Abstract][Full Text] [Related]
29. Cholangiocarcinoma cell proliferation is enhanced in primary sclerosing cholangitis: A role for IL-17A.
Lieshout R; Kamp EJCA; Verstegen MMA; Doukas M; Dinjens WNM; Köten K; IJzermans JNM; Bruno MJ; Peppelenbosch MP; van der Laan LJW; de Vries AC
Int J Cancer; 2023 Jun; 152(12):2607-2614. PubMed ID: 36346104
[TBL] [Abstract][Full Text] [Related]
30. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma.
Kerr SE; Barr Fritcher EG; Campion MB; Voss JS; Kipp BR; Halling KC; Lewis JT
Hum Pathol; 2014 Sep; 45(9):1797-804. PubMed ID: 25027853
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma.
Voigtländer T; Gupta SK; Thum S; Fendrich J; Manns MP; Lankisch TO; Thum T
PLoS One; 2015; 10(10):e0139305. PubMed ID: 26431155
[TBL] [Abstract][Full Text] [Related]
32. Increased serum levels of carbohydrate antigen 19-9 and outcomes in primary sclerosing cholangitis patients without cholangiocarcinoma.
Venkatesh PG; Navaneethan U; Shen B; McCullough AJ
Dig Dis Sci; 2013 Mar; 58(3):850-7. PubMed ID: 23007734
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
Taghavi SA; Eshraghian A; Niknam R; Sivandzadeh GR; Bagheri Lankarani K
Expert Rev Gastroenterol Hepatol; 2018 Jun; 12(6):575-584. PubMed ID: 29781738
[TBL] [Abstract][Full Text] [Related]
34. Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis.
Quinn KP; Tabibian JH; Lindor KD
Scand J Gastroenterol; 2017 Apr; 52(4):377-381. PubMed ID: 27908204
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs and extracellular vesicles in cholangiopathies.
Olaizola P; Lee-Law PY; Arbelaiz A; Lapitz A; Perugorria MJ; Bujanda L; Banales JM
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1293-1307. PubMed ID: 28711597
[TBL] [Abstract][Full Text] [Related]
36. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
Burak K; Angulo P; Pasha TM; Egan K; Petz J; Lindor KD
Am J Gastroenterol; 2004 Mar; 99(3):523-6. PubMed ID: 15056096
[TBL] [Abstract][Full Text] [Related]
37. [Proteomic analysis of serum and serum exosomes, and their application in intrahepatic cholangiocarcinoma].
Yang K; Wang W; Wang Y; Yan C
Se Pu; 2021 Nov; 39(11):1191-1202. PubMed ID: 34677014
[TBL] [Abstract][Full Text] [Related]
38. Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2
Kennedy L; Hargrove L; Demieville J; Karstens W; Jones H; DeMorrow S; Meng F; Invernizzi P; Bernuzzi F; Alpini G; Smith S; Akers A; Meadows V; Francis H
Hepatology; 2018 Sep; 68(3):1042-1056. PubMed ID: 29601088
[TBL] [Abstract][Full Text] [Related]
39. Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.
Melum E; Karlsen TH; Schrumpf E; Bergquist A; Thorsby E; Boberg KM; Lie BA
Hepatology; 2008 Jan; 47(1):90-6. PubMed ID: 18023027
[TBL] [Abstract][Full Text] [Related]
40. Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis.
Lankisch TO; Metzger J; Negm AA; Vosskuhl K; Schiffer E; Siwy J; Weismüller TJ; Schneider AS; Thedieck K; Baumeister R; Zürbig P; Weissinger EM; Manns MP; Mischak H; Wedemeyer J
Hepatology; 2011 Mar; 53(3):875-84. PubMed ID: 21374660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]